enzalutamide
pfizer,astellas
['enzamet']
lba - updated os in enzamet med f/u: 68 m mos: enza nr (95% ci nr nr) v control 73.2 m (95% ci 64.7 nr) early doc planned: yes (hr 0.82, ci 0.63-1.06), no (hr 0.60, ci 0.47-0.78) vol of dx: low (hr 0.54, ci 0.39-0.74), high (hr 0.79, ci 0.63-0.98) #asco22 
Uro Onc @GACancerCenter | Res PD & Ronald W. Lewis MD Chair of Uro Educ @mcg_urology | Digital Media Ed @EUplatinum | #mentalhealth research | @urotoday